Chapter/Section Purchase

Leave This Empty:

Global Tuberculosis Testing and Diagnostics Market Insights, Forecast to 2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Smear Microscopy
1.2.3 Nucleic Acid Testing
1.2.4 Radiography
1.2.5 Tuberculin Skin Test (TST)
1.2.6 Interferon Gamma Released Assay (IGRA)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Tuberculosis Testing and Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Testing and Diagnostics Market Perspective (2017-2028)
2.2 Tuberculosis Testing and Diagnostics Growth Trends by Region
2.2.1 Tuberculosis Testing and Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Tuberculosis Testing and Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Tuberculosis Testing and Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Tuberculosis Testing and Diagnostics Market Dynamics
2.3.1 Tuberculosis Testing and Diagnostics Industry Trends
2.3.2 Tuberculosis Testing and Diagnostics Market Drivers
2.3.3 Tuberculosis Testing and Diagnostics Market Challenges
2.3.4 Tuberculosis Testing and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Testing and Diagnostics Players by Revenue
3.1.1 Global Top Tuberculosis Testing and Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Tuberculosis Testing and Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Tuberculosis Testing and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis Testing and Diagnostics Revenue
3.4 Global Tuberculosis Testing and Diagnostics Market Concentration Ratio
3.4.1 Global Tuberculosis Testing and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis Testing and Diagnostics Revenue in 2021
3.5 Tuberculosis Testing and Diagnostics Key Players Head office and Area Served
3.6 Key Players Tuberculosis Testing and Diagnostics Product Solution and Service
3.7 Date of Enter into Tuberculosis Testing and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis Testing and Diagnostics Breakdown Data by Type
4.1 Global Tuberculosis Testing and Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Type (2023-2028)
5 Tuberculosis Testing and Diagnostics Breakdown Data by Application
5.1 Global Tuberculosis Testing and Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Tuberculosis Testing and Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Tuberculosis Testing and Diagnostics Market Size (2017-2028)
6.2 North America Tuberculosis Testing and Diagnostics Market Size by Type
6.2.1 North America Tuberculosis Testing and Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Tuberculosis Testing and Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Tuberculosis Testing and Diagnostics Market Share by Type (2017-2028)
6.3 North America Tuberculosis Testing and Diagnostics Market Size by Application
6.3.1 North America Tuberculosis Testing and Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Tuberculosis Testing and Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Tuberculosis Testing and Diagnostics Market Share by Application (2017-2028)
6.4 North America Tuberculosis Testing and Diagnostics Market Size by Country
6.4.1 North America Tuberculosis Testing and Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Tuberculosis Testing and Diagnostics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Tuberculosis Testing and Diagnostics Market Size (2017-2028)
7.2 Europe Tuberculosis Testing and Diagnostics Market Size by Type
7.2.1 Europe Tuberculosis Testing and Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Tuberculosis Testing and Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Tuberculosis Testing and Diagnostics Market Share by Type (2017-2028)
7.3 Europe Tuberculosis Testing and Diagnostics Market Size by Application
7.3.1 Europe Tuberculosis Testing and Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Tuberculosis Testing and Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Tuberculosis Testing and Diagnostics Market Share by Application (2017-2028)
7.4 Europe Tuberculosis Testing and Diagnostics Market Size by Country
7.4.1 Europe Tuberculosis Testing and Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Tuberculosis Testing and Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type
8.2.1 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Tuberculosis Testing and Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application
8.3.1 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Tuberculosis Testing and Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region
8.4.1 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tuberculosis Testing and Diagnostics Market Size (2017-2028)
9.2 Latin America Tuberculosis Testing and Diagnostics Market Size by Type
9.2.1 Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Tuberculosis Testing and Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Tuberculosis Testing and Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Tuberculosis Testing and Diagnostics Market Size by Application
9.3.1 Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Tuberculosis Testing and Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Tuberculosis Testing and Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Tuberculosis Testing and Diagnostics Market Size by Country
9.4.1 Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Tuberculosis Testing and Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type
10.2.1 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Tuberculosis Testing and Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application
10.3.1 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Tuberculosis Testing and Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country
10.4.1 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Tuberculosis Testing and Diagnostics Introduction
11.1.4 Roche Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.1.5 Roche Recent Developments
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Details
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Introduction
11.2.4 Thermo Fischer Scientific Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.2.5 Thermo Fischer Scientific Recent Developments
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Tuberculosis Testing and Diagnostics Introduction
11.3.4 Becton Dickinson Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.3.5 Becton Dickinson Recent Developments
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Tuberculosis Testing and Diagnostics Introduction
11.4.4 Abbott Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.4.5 Abbott Recent Developments
11.5 Hologic
11.5.1 Hologic Company Details
11.5.2 Hologic Business Overview
11.5.3 Hologic Tuberculosis Testing and Diagnostics Introduction
11.5.4 Hologic Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.5.5 Hologic Recent Developments
11.6 Qiagen
11.6.1 Qiagen Company Details
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Tuberculosis Testing and Diagnostics Introduction
11.6.4 Qiagen Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.6.5 Qiagen Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Tuberculosis Testing and Diagnostics Introduction
11.7.4 Sanofi Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.7.5 Sanofi Recent Developments
11.8 Oxford Immunotec
11.8.1 Oxford Immunotec Company Details
11.8.2 Oxford Immunotec Business Overview
11.8.3 Oxford Immunotec Tuberculosis Testing and Diagnostics Introduction
11.8.4 Oxford Immunotec Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.8.5 Oxford Immunotec Recent Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Tuberculosis Testing and Diagnostics Introduction
11.9.4 BioMerieux Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.9.5 BioMerieux Recent Developments
11.10 Par Sterile
11.10.1 Par Sterile Company Details
11.10.2 Par Sterile Business Overview
11.10.3 Par Sterile Tuberculosis Testing and Diagnostics Introduction
11.10.4 Par Sterile Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.10.5 Par Sterile Recent Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Details
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Introduction
11.11.4 Bio-Rad Laboratories Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.11.5 Bio-Rad Laboratories Recent Developments
11.12 Akonni Biosystems
11.12.1 Akonni Biosystems Company Details
11.12.2 Akonni Biosystems Business Overview
11.12.3 Akonni Biosystems Tuberculosis Testing and Diagnostics Introduction
11.12.4 Akonni Biosystems Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.12.5 Akonni Biosystems Recent Developments
11.13 Cepheid
11.13.1 Cepheid Company Details
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Tuberculosis Testing and Diagnostics Introduction
11.13.4 Cepheid Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.13.5 Cepheid Recent Developments
11.14 Siemens Healthineer
11.14.1 Siemens Healthineer Company Details
11.14.2 Siemens Healthineer Business Overview
11.14.3 Siemens Healthineer Tuberculosis Testing and Diagnostics Introduction
11.14.4 Siemens Healthineer Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.14.5 Siemens Healthineer Recent Developments
11.15 Hain Lifescience
11.15.1 Hain Lifescience Company Details
11.15.2 Hain Lifescience Business Overview
11.15.3 Hain Lifescience Tuberculosis Testing and Diagnostics Introduction
11.15.4 Hain Lifescience Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.15.5 Hain Lifescience Recent Developments
11.16 Epistem
11.16.1 Epistem Company Details
11.16.2 Epistem Business Overview
11.16.3 Epistem Tuberculosis Testing and Diagnostics Introduction
11.16.4 Epistem Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.16.5 Epistem Recent Developments
11.17 Creative Diagnostics
11.17.1 Creative Diagnostics Company Details
11.17.2 Creative Diagnostics Business Overview
11.17.3 Creative Diagnostics Tuberculosis Testing and Diagnostics Introduction
11.17.4 Creative Diagnostics Revenue in Tuberculosis Testing and Diagnostics Business (2017-2022)
11.17.5 Creative Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer